FLT3 INTERNAL TANDEM DUPLICATION POSITIVE

Clinical trials for FLT3 INTERNAL TANDEM DUPLICATION POSITIVE explained in plain language.

Never miss a new study

Get alerted when new FLT3 INTERNAL TANDEM DUPLICATION POSITIVE trials appear

Sign up with your email to follow new studies for FLT3 INTERNAL TANDEM DUPLICATION POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Scientists test new drug combo to fight blood cancer, hoping to spare patients from transplants

Disease control Recruiting now

This study is testing a new treatment plan for adults with a specific genetic type of acute myeloid leukemia (AML). The goal is to see if a combination of targeted drugs and chemotherapy can control the cancer so well that a risky stem cell transplant might be avoided. Researcher…

Matched conditions: FLT3 INTERNAL TANDEM DUPLICATION POSITIVE

Phase: PHASE2 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control

Last updated Mar 24, 2026 12:02 UTC

FLT3 INTERNAL TANDEM DUPLICATION POSITIVE

Get alerted when new FLT3 INTERNAL TANDEM DUPLICATION POSITIVE trials appear

Scientists test new drug combo to fight blood cancer, hoping to spare patients from transplants